SecBot SecBot

LNAI

Lunai Bioworks Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001527728 Biotech & Drug Discovery
$0.2648 −0.03 (−10.24%)
Oct 26 4:00 PM ET · prev $0.2950
Market cap
$2.4M
Nano cap
Next earnings
Nov 12
in 17 days
1 year
−96.8%
from $8.40 · Oct 27
30 days
−85.8%
from $1.86
52-week range
$0.2648–12.00
at the low
Avg volume 20D
605.2K
Oct 23 spike 9.37M
Short interest
148.1K
≈3.3% of shares · +10.8%
Days to cover
2.6
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
10
analyzed by SecBot
SecBot read BEARISH 4 reports · 90 days
Balance 4 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 3/4 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH Lunai Bioworks received a Nasdaq delisting determination due to a stockholders' deficit of $(9,024,946)…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2026: 2 added (0 new), 2 trimmed or exited.

  • Short sellersSTEADY

    Short interest +10.8% to 148.1K shares. 2.6 days to cover, ≈3.3% of shares.

  • TrendDOWNTREND

    85% below its 50-day average. New closing low $0.2648 on Oct 26.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 1.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCADD182,237$74.3K
UBS Group AGTRIM11,439$4.7K
GROUP ONE TRADING LLCDOUBLED4,360$1.8K
SIMPLEX TRADING, LLCNEAR_EXIT1,107$451.00
NORTHERN TRUST CORPADD37,402$33.0K
UBS Group AGTRIM17,940$15.8K
BANK OF AMERICA CORP /DE/NEAR_EXIT257$226.00

Quarterly 13F filings are due 45 days after each quarter ends.

Reddit
Recent posts
r/pennystocks Neutral 25d ago
$LNAI -"Lunai Bioworks (LNAI): Second Amended Complaint filed in D. Del., No. 1:26-cv-00549
1 upvotes · 1 comments
All social signals and their track records

Earnings setup

Estimates
Nov 12
reports in 17 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
LNAI Q1 2027 Earnings Scheduled — 2026-11-12
Recent
Oct 2, 2026
Earnings date
LNAI Q4 2026 Earnings Scheduled — 2026-10-02
Sep 28, 2026
Earnings date
LNAI Q4 2026 Earnings Scheduled — 2026-09-28
Sep 22, 2026
Press release
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Exclusive worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's workflow, connecting patient-derived subtypes with…
Sep 4, 2026
Press release
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
Correction Updates a Reference Link; No Other Content in the Original Release Has Changed WILMINGTON, Del. and SACRAMENTO, Calif., Sept. 4, 2026…
Aug 27, 2026
Press release
Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10b-5 WILMINGTON, Del. and SACRAMENTO, Calif., Aug. 27, 2026…

Short side

FINRA· Sep 30, 2026
148,144
shares short
+10.8%
vs prior settlement
2.6
days to cover
≈3.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Lunai Bioworks received a Nasdaq delisting determination due to a stockholders' deficit of $(9,024,946), violating the…
8-K — Impact 9/10
Oct 15, 2026 SEC
William Anderson Wittekind filed Amendment No. 25 to his Schedule 13D, reporting that his beneficial ownership of…
SC 13D/A — Impact 6/10
Oct 9, 2026 SEC
Lunai Bioworks submitted a formal request to Nasdaq on October 9, 2026, asking for an immediate trading suspension in…
8-K — Impact 6/10
Oct 2, 2026 Earnings calendar
LNAI Q4 2026 Earnings Scheduled — 2026-10-02
Mar 31, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — ADD
182,237 shares ($74.3K)
Mar 31, 2026 Inst.
UBS Group AG — TRIM
11,439 shares ($4.7K)

SecBot reports

10 filings · 0 bullish · 6 bearish · 2 mixed · 2 neutral
All LNAI filing & press-release reports (10)